Literature DB >> 11903082

The effect of sevoflurane on glutamate release and uptake in rat cerebrocortical presynaptic terminals.

M L Vinje1, M C Moe, E T Valø, J Berg-Johnsen.   

Abstract

BACKGROUND: Volatile anaesthetics exert their effect in the brain mainly by reducing synaptic excitability. Isoflurane abates excitation by reducing the release and increasing the uptake of transmitter glutamate into the presynaptic terminal. The exact molecular mechanisms exerting these effects, however, are not clear. Voltage-gated calcium channels have been proposed as the pharmacological target. The present study examines the effect of sevoflurane on synaptic glutamate release and free cytosolic calcium and the effect on high- and low-affinity uptake of L-glutamate using isolated presynaptic terminals prepared from rat cerebral cortex.
METHODS: Released glutamate was measured fluorometrically in a spectrophotometer as the fluorescence of NADPH and calcium as the fluorescence of fura-2. 4-aminopyridine was used to induce membrane depolarization. Glutamate uptake was measured in a series of different concentrations of L-glutamate corresponding to the high- and the low- affinity uptake systems adding a fixed concentration og radiolabelled glutamate. The labelling was measured by counting disintegrations per min in a beta-scintillation counter.
RESULTS: Sevoflurane reduced the calcium-dependent glutamate release in a dose-dependent manner as sevoflurane 1.5, 2.5 and 4.0% reduced the release by 58, 69 and 94%, respectively (P<0.05). Membrane depolarization induced an increase in free cytosolic calcium by 25%. Sevoflurane did not affect this increase. Neither the high- nor the low-affinity uptake transporter systems are affected by the anaesthetic.
CONCLUSION: These results indicate that different volatile anaesthetics may act differently on the presynaptic terminal. The exact modes of action have to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11903082     DOI: 10.1046/j.0001-5172.2001.00412.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

Review 1.  Neurochemical modulators of sleep and anesthetic states.

Authors:  Christa J Van Dort; Helen A Baghdoyan; Ralph Lydic
Journal:  Int Anesthesiol Clin       Date:  2008

2.  Dose-dependent influence of sevoflurane anesthesia on neuronal survival and cognitive outcome after transient forebrain ischemia in Sprague-Dawley rats.

Authors:  Irina Lasarzik; Rüdiger R Noppens; Thorsten Wolf; Henrike Bauer; Clara Luh; Christian Werner; Kristin Engelhard; Serge C Thal
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

3.  The effect of sevoflurane and isoflurane anesthesia on single unit and local field potentials.

Authors:  Daniil P Aksenov; Michael J Miller; Conor J Dixon; Alice M Wyrwicz
Journal:  Exp Brain Res       Date:  2019-03-27       Impact factor: 1.972

4.  Anesthetic effects on regional CBF, BOLD, and the coupling between task-induced changes in CBF and BOLD: an fMRI study in normal human subjects.

Authors:  Maolin Qiu; Ramachandran Ramani; Michael Swetye; Nallakkandi Rajeevan; R Todd Constable
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

5.  Brain tissue oxygen regulation in awake and anesthetized neonates.

Authors:  Daniil P Aksenov; Andrey V Dmitriev; Michael J Miller; Alice M Wyrwicz; Robert A Linsenmeier
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

Review 6.  Neonatal Anesthesia and Oxidative Stress.

Authors:  David A Gascoigne; Mohammed M Minhaj; Daniil P Aksenov
Journal:  Antioxidants (Basel)       Date:  2022-04-16

7.  Sevoflurane anesthesia improves cognitive performance in mice, but does not influence in vitro long-term potentation in hippocampus CA1 stratum radiatum.

Authors:  Rainer Haseneder; Laura Starker; Jasmin Berkmann; Kristine Kellermann; Bettina Jungwirth; Manfred Blobner; Matthias Eder; Eberhard Kochs; Gerhard Rammes
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.